Determinants of response to CDK4/6 inhibitors in the real-world setting

Despite widespread use and a known mechanism of action for CDK4/6 inhibitors in combination with endocrine therapy, features of disease evolution and determinants of therapeutic response in the real-world setting remain unclear. Here, a cohort of patients treated with standard-of-care combination re...

Descripción completa

Detalles Bibliográficos
Autores principales: Witkiewicz, Agnieszka K., Schultz, Emily, Wang, Jianxin, Hamilton, Deanna, Levine, Ellis, O’Connor, Tracey, Knudsen, Erik S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499925/
https://www.ncbi.nlm.nih.gov/pubmed/37704753
http://dx.doi.org/10.1038/s41698-023-00438-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499925/
https://www.ncbi.nlm.nih.gov/pubmed/37704753
http://dx.doi.org/10.1038/s41698-023-00438-0

Ejemplares similares